Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-238-7 | CAS number: 55-56-1
Endpoint summary
Administrative data
Description of key information
The acute toxicity of chlorhexidine was tested for the oral and dermal route and in both cases the acute toxicity was low.
For the inhalatory route there are no studies available. However, due to the physico-chemical properties of the substance, exposure via inhalation is unlikely. Therefore, testing for acute inhalation toxicity is scientifically not justified.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
Acute toxicity: via dermal route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 2 815 mg/kg bw
Additional information
Acute oral toxicity
The acute oral toxicity of chlorhexidine was tested in a study (method comparable to OECD guideline 401; no GLP) with groups of at least 5 male and 5 female Wistar rats. The LD50 values for male and female animals were approximately 5000 mg/kg bw. Clinical signs included psychomotor depression, ataxia, depressed respiratory rate, sporadic incidences of ptosis, chromodacryorrhoea, epistaxis and diarrhea.
In several other studies with rats and mice comparable or even higher LD50 values were obtained.
Acute dermal toxicity
The acute dermal toxicity chlorhexidine (administered as chlorhexidine digluconate) was tested in a study (method according to US EPA Proposed Guideline for Toxicology – Section 162.81-2) with 2 male and 2 female rabbits dosed with 5000 mg/kg bw. Under the conditions of the assay, 2815 mg/kg bw of chlorhexidine base caused no deaths. Moderate to severe skin irritation was observed that subsided in most animals within one week but led to epidermal scrubbing in one animal.
Acute inhalation toxicity
There are no studies available performed with chlorhexidine gluconate. Due to the physico-chemical properties of the substance, exposure via inhalation is unlikely. Therefore, testing for acute inhalation toxicity is scientifically not justified.
Justification for classification or non-classification
For both routes (oral and dermal) the acute toxicity of chlorhexidine when administered as chlorhexidine digluconate is low.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
